About Fractyl
Fractyl is a company based in Lexington (United States) founded in 2010. Fractyl has raised $345.27 million across 7 funding rounds from investors including Bessemer Venture Partners, Maverick Ventures and M28 Capital. The company has 107 employees as of December 31, 2024. Fractyl offers products and services including Revita and Rejuva. Fractyl operates in a competitive market with competitors including Adocia, BioAge Labs, Antag Therapeutics, Carmot and Altimmune, among others.
- Headquarter Lexington, United States
- Employees 107 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Fractyl Health, Inc.
-
Annual Revenue
$93 K (USD)-22.5as on Dec 31, 2024
-
Net Profit
-$68.69 M (USD)10.89as on Dec 31, 2024
-
EBITDA
-$92.85 M (USD)-83.69as on Dec 31, 2024
-
Total Equity Funding
$345.27 M (USD)
in 7 rounds
-
Latest Funding Round
$100 M (USD), Series F
Jun 16, 2021
-
Investors
Bessemer Venture Partners
& 17 more
-
Employee Count
107
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Fractyl
Fractyl is a publicly listed company on the NASDAQ with ticker symbol GUTS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Fractyl
Fractyl offers a comprehensive portfolio of products and services, including Revita and Rejuva.
Outpatient procedure to resurface duodenum for obesity root cause treatment
Platform for long-term remission of obesity and type 2 diabetes
People of Fractyl
Unlock access to complete
Funding Insights of Fractyl
Fractyl has successfully raised a total of $345.27M across 7 strategic funding rounds. The most recent funding activity was a Series F round of $100 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Fractyl
Fractyl has secured backing from 18 investors, including venture fund and institutional investors. Prominent investors backing the company include Bessemer Venture Partners, Maverick Ventures and M28 Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage tech and life-sciences firms are funded across the US.
|
Locked | Locked | Locked | |
|
A firm focused on biotechnology investments for prevalent diseases is operated.
|
Locked | Locked | Locked | |
|
VC firm focusing on technology companies
|
Locked | Locked | Locked |
Investor details for Fractyl
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fractyl
Investment portfolio details for Fractyl
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Fractyl
Detailed financials for Fractyl
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fractyl Comparisons
Peer comparison for Fractyl
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fractyl
Fractyl operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adocia, BioAge Labs, Antag Therapeutics, Carmot and Altimmune, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| Locked | Locked | Locked |
Peptide-based therapies for obesity and cardiometabolic disorders are developed.
|
|
| Locked | Locked | Locked |
Disease-modifying therapies for metabolic diseases are developed.
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases and solid tumors are developed.
|
Detailed competitors of Fractyl
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fractyl
Complete news archive for Fractyl
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fractyl
Fractyl was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Fractyl is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Fractyl is a funded company, having raised a total of $345.27M across 7 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Fractyl is 107.
Annual revenue of Fractyl is $93K as on Dec 31, 2024.
Fractyl was founded in 2010 and is headquartered in Lexington, United States. Operations focus on the medical device sector, where an investigational trans-oral procedure called Revita duodenal mucosal resurfacing (DMR) is developed to address type-2 diabetes. The procedure, performed via the proprietary Revita System, involves hydrothermal ablation of the duodenal lining to influence glucose control and insulin resistance. A console and single-use balloon catheter are utilized in the process.
Fractyl's top competitors include Adocia, BioAge Labs and Carmot.
Fractyl offers Revita and Rejuva.
Yes, Fractyl is publicly traded on NASDAQ under the ticker symbol GUTS.
Fractyl has 18 investors. Key investors include Bessemer Venture Partners, Maverick Ventures, M28 Capital, Population Health Partners, and Taiwania Capital.
The ticker symbol of Fractyl is GUTS on NASDAQ.